EDA ligand triggers plasma membrane trafficking of its receptor EDAR via PKA activation and SNAP23-containing complexes

  • Cell Biosci. 2023 Jul 10;13(1):128. doi: 10.1186/s13578-023-01082-8.
Yuyuan Yao  1 Ruihan Yang  1 Jian Zhu  2 David Schlessinger  3 Jian Sima  4
Affiliations
  • 1. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • 2. Department of Psychology, Eastern Illinois University, Charleston, IL, 61920, USA.
  • 3. Laboratory of Genetics and Genomics, NIA/NIH-IRP, 251 Bayview Blvd, Room 10B014, Baltimore, MD, 21224, USA.
  • 4. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. [email protected].
Abstract

Background: Ectodysplasin-A (EDA), a skin-specific TNF ligand, interacts with its membrane receptor EDAR to trigger EDA signaling in skin appendage formation. Gene mutations in EDA signaling cause Anhidrotic/Hypohidrotic Ectodermal Dysplasia (A/HED), which affects the formation of skin appendages including hair, teeth, and several exocrine glands.

Results: We report that EDA triggers the translocation of its receptor EDAR from a cytosolic compartment into the plasma membrane. We use protein affinity purification to show that upon EDA stimulation EDAR associates with SNAP23-STX6-VAMP1/2/3 vesicle trafficking complexes. We find that EDA-dependent PKA activation is critical for the association. Notably, either of two HED-linked EDAR mutations, T346M and R420W, prevents EDA-induced EDAR translocation; and both EDA-induced PKA activation and SNAP23 are required for Meibomian gland (MG) growth in a skin appendage model.

Conclusions: Overall, in a novel regulatory mechanism, EDA increases plasma membrane translocation of its own receptor EDAR, augmenting EDA-EDAR signaling in skin appendage formation. Our findings also provide PKA and SNAP23 as potential targets for the intervention of HED.

Keywords
EDA; EDAR; HED; Membrane trafficking; TNFR.
Products